Thiopyrans
Medchemexpress LLC Tazarotene | 118292-40-3 | MFCD00867628 | C21H21NO2S | 1 ML
Tazarotene (AGN 190168) is a selective retinoic acid receptor (RAR) agonist used for treating plaque psoriasis and acne vulgaris. It is also a click chemistry reagent containing an Alkyne group, enabling it to undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
- Selective retinoic acid receptor (RAR) agonist
- Used for treating plaque psoriasis
- Used for treating acne vulgaris
- Functions as a click chemistry reagent
- Contains an alkyne group for CuAAc reactions
Medchemexpress LLC Tazarotene (Standard) | 118292-40-3 | C21H21NO2S | 5 MG
Tazarotene (Standard) is the analytical standard of Tazarotene, intended for research and analytical applications. It acts as a selective retinoic acid receptor (RAR) agonist, used in the treatment of plaque psoriasis and acne vulgaris. As a click chemistry reagent, it contains an alkyne group for copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions.
- Analytical standard for research and analytical applications
- Selective retinoic acid receptor (RAR) agonist
- Treats plaque psoriasis and acne vulgaris
- Click chemistry reagent with alkyne group
- Enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions
Medchemexpress LLC Tazarotene (AGN 190168) | 118292-40-3 | C21H21NO2S | 5 MG
Tazarotene (AGN 190168) is a selective retinoic acid receptor (RAR) agonist used for treating plaque psoriasis and acne vulgaris. It is also a click chemistry reagent, containing an Alkyne group that can participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
- Used for monotherapy or adjuvant therapy for psoriasis and acne
- Upregulates tumor suppressor tazarotene induced gene 3
- Suppresses gene expression of MRP-8 and SKALP in human epidermal cell cultures
- Delivered into the skin via topical gel application
- Metabolized to active tazarotenic acid with short systemic residence time
- Blocks induction of ornithine decarboxylase activity
Medchemexpress LLC Tazarotene (standard) | 118292-40-3 | C21H21NO2S | 50 MG
Tazarotene (Standard) is an analytical standard intended for research and analytical applications. It acts as a selective retinoic acid receptor (RAR) agonist, used in the treatment of plaque psoriasis and acne vulgaris. It is also a click chemistry reagent, containing an alkyne group that can participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules that have azide groups.
- Analytical standard for research and analytical applications
- Selective retinoic acid receptor (RAR) agonist
- Used in the treatment of plaque psoriasis and acne vulgaris
- Click chemistry reagent containing an alkyne group
- Participates in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide groups
- Commonly used in qualitative, quantitative, and methodological research experiments
- Applicable in HPLC, GC, and MS
Medchemexpress LLC Tazarotene (standard) | 118292-40-3 | MFCD00867628 | C21H21NO2S | 100 MG
Tazarotene (Standard) is an analytical standard intended for research and analytical applications. It is a selective retinoic acid receptor (RAR) agonist used for the treatment of plaque psoriasis and acne vulgaris. This compound is also a click chemistry reagent, containing an Alkyne group, capable of undergoing copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. As an analytical standard, it serves as a reference for qualitative, quantitative, and methodological research experiments in techniques such as HPLC, GC, and MS.
Apexbio Technology LLC Tazarotene 118292-40-3 25mg
Tazarotene (118292-40-3) is a small-molecule agonist targeting retinoic acid receptors (RARs) primarily the RAR- and RAR- subtypes It is designed to modulate gene transcription via selective activation of RARs thereby regulating cellular processes such as proliferation differentiation and apoptosis Tazarotene exerts its biological activity through rapid hydrolysis to its active metabolite tazarotenic acid which binds to RARs and induces expression of genes including the tumor suppressor TIG3 Based on these pharmacological properties Tazarotene holds research potential in the topical treatment of dermatological conditions such as psoriasis acne vulgaris and hyperproliferative skin disorders as well as in mechanistic studies of retinoid-responsive signaling pathways
Apexbio Technology LLC Tazarotene 118292-40-3 5mg
Tazarotene (118292-40-3) is a small-molecule agonist targeting retinoic acid receptors (RARs) primarily the RAR- and RAR- subtypes It is designed to modulate gene transcription via selective activation of RARs thereby regulating cellular processes such as proliferation differentiation and apoptosis Tazarotene exerts its biological activity through rapid hydrolysis to its active metabolite tazarotenic acid which binds to RARs and induces expression of genes including the tumor suppressor TIG3 Based on these pharmacological properties Tazarotene holds research potential in the topical treatment of dermatological conditions such as psoriasis acne vulgaris and hyperproliferative skin disorders as well as in mechanistic studies of retinoid-responsive signaling pathways
Apexbio Technology LLC Tazarotene 118292-40-3 10mM (in 1mL DMSO)
Tazarotene (118292-40-3) is a small-molecule agonist targeting retinoic acid receptors (RARs) primarily the RAR- and RAR- subtypes It is designed to modulate gene transcription via selective activation of RARs thereby regulating cellular processes such as proliferation differentiation and apoptosis Tazarotene exerts its biological activity through rapid hydrolysis to its active metabolite tazarotenic acid which binds to RARs and induces expression of genes including the tumor suppressor TIG3 Based on these pharmacological properties Tazarotene holds research potential in the topical treatment of dermatological conditions such as psoriasis acne vulgaris and hyperproliferative skin disorders as well as in mechanistic studies of retinoid-responsive signaling pathways
Apexbio Technology LLC Tazarotene 118292-40-3 100mg
Tazarotene (118292-40-3) is a small-molecule agonist targeting retinoic acid receptors (RARs) primarily the RAR- and RAR- subtypes It is designed to modulate gene transcription via selective activation of RARs thereby regulating cellular processes such as proliferation differentiation and apoptosis Tazarotene exerts its biological activity through rapid hydrolysis to its active metabolite tazarotenic acid which binds to RARs and induces expression of genes including the tumor suppressor TIG3 Based on these pharmacological properties Tazarotene holds research potential in the topical treatment of dermatological conditions such as psoriasis acne vulgaris and hyperproliferative skin disorders as well as in mechanistic studies of retinoid-responsive signaling pathways